Hospital operator Tenet Healthcare (NYSE: THC) will be announcing earnings results this Tuesday before market open. Here’s what you need to know.

Tenet Healthcare beat analysts’ revenue expectations by 1.3% last quarter, reporting revenues of $5.22 billion, down 2.7% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ EPS estimates and a solid beat of analysts’ full-year EPS guidance estimates.

Is Tenet Healthcare a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting Tenet Healthcare’s revenue to be flat year on year at $5.15 billion, in line with its flat revenue from the same quarter last year. Adjusted earnings are expected to come in at $2.87 per share.

The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Tenet Healthcare has only missed Wall Street’s revenue estimates once over the last two years, exceeding top-line expectations by 1.9% on average.

Looking at Tenet Healthcare’s peers in the healthcare providers & services segment, only Elevance Health has reported results so far. It beat analysts’ revenue estimates by 3%, delivering year-on-year sales growth of 13.4%. The stock was down 19.7% on the results.

The euphoria surrounding Trump’s November win lit a fire under major indices, but potential tariffs have caused the market to do a 180 in 2025. While some of the healthcare providers & services stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 2.3% on average over the last month. Tenet Healthcare is up 3.5% during the same time and is heading into earnings with an average analyst price target of $188.71 (compared to the current share price of $175.06).

Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.